BeStock  
Stocks › Biotechnology › PHAR

Pharming Group PHAR

US equityMarket cap rank #3287Biotechnology
$11.54 −$0.63 (-5.18%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $11.54 0.00%
Open$11.85
Prev close$12.17
Day range$11.30 – $11.97
Volume10.5K
Market cap$816.78M
P/E (TTM)35.0
Dividend yield–

PHAR Stock News

Headlines matching Pharming Group or the PHAR ticker, most recent first.

  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38Market news · 30 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 30 Sep 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $38 PositiveMarket news · 3 Aug 2026 · Direct mention
  • EXTRAWELL PHAR: FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M.HKEX · 30 Jul 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 23 Jun 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 8 May 2026 · Direct mention
  • CCORF Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $37Market news · 10 Apr 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $41 NegativeMarket news · 13 Mar 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $42Market news · 4 Feb 2026 · Direct mention
  • H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 7 Nov 2026 · Direct mention
  • EXTRAWELL PHAR: FORM OF PROXY FOR SPECIAL GENERAL MEETING TO BE HELD ON MONDAY, 30 NOVEMBER 2026 AT 10:00 A.M.HKEX · 5 Nov 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $41 PositiveMarket news · 29 Oct 2026 · Direct mention
  • H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 28 Oct 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38Market news · 23 Oct 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38Market news · 15 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PHAR.

Sign in to join the discussion.

Scroll to Top